EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating 4-Hydroxynonenal Is Associated with Clinical Severity in ST-Segment Elevation Myocardial Infarction

Ángel Priego-Ranero, Brandon Fisher-Bautista iD, Rashidi Springall iD, Luis M Amezcua-Guerra, Héctor González-Pacheco, Pedro Ruiz-Garcia iD, Betsabé Jaramillo-Antonio iD, Malinalli Brianza-Padilla, Gabriela Fonseca-Camarillo iD

International Journal of Molecular Sciences · 29.10.2026 · 27 (21) · 9694

DOI: 10.3390/ijms27219694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.10.2026. Verfasst von Ángel Priego-Ranero und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Inmunología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico. Hauptthemen laut MEDLINE: Aldehydes, ST Elevation Myocardial Infarction. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Cardiología, Instituto Nacional de Cardiología Ignacio Chávez.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress and ferroptosis are increasingly recognized as key contributors to the pathogenesis of ST-segment elevation myocardial infarction (STEMI), although the clinical relevance of circulating molecules linked to these processes remains insufficiently defined. The present study evaluated serum levels of the lipid peroxidation marker 4-hydroxynonenal (4-HNE), as well as glutathione peroxidase 4 (GPX4), in patients with STEMI and controls, and explored their relationship with clinical severity. Serum concentrations of 4-HNE and GPX4 were measured, and their associations with clinical risk scores and major outcomes were analyzed using correlation and regression methods. Compared with controls, patients with STEMI showed significantly higher 4-HNE concentrations (median, 1220.2 [IQR, 806–1453] vs. 38.7 [15.6–584]; p < 0.001), whereas GPX4 levels were significantly lower in STEMI patients (median, 8.85 [8–10.56] vs. controls 10.50 [9.31–12.11]; p = 0.003). Increased 4-HNE levels were positively associated with the TIMI score (ρ = 0.385, FDR-adjusted p = 0.026) and Killip–Kimball class (ρ = 0.329, p = 0.016; FDR-adjusted p = 0.041), suggesting a relationship with greater clinical severity. Although unadjusted analysis indicated an association between higher 4-HNE concentrations and cardiovascular mortality (OR, 1.0033; 95% CI, 1.0004–1.0083; p = 0.0176), this finding was not significant after multivariable adjustment. Overall, these findings indicate that STEMI is associated with increased lipid peroxidation and reduced GPX4 levels, supporting the involvement of ferroptosis-related pathways in acute myocardial infarction. Elevated 4-HNE levels were also associated with greater clinical severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AldehydesST Elevation Myocardial InfarctionHumansFemaleMaleBiomarkersMiddle AgedPhospholipid Hydroperoxide Glutathione PeroxidaseSeverity of Illness IndexLipid PeroxidationAgedFerroptosisOxidative Stress

Stichwörter der Autor:innen

4-HNEGPX4STEMIferroptosis

Substanzen

Aldehydes4-hydroxy-2-nonenalBiomarkersPhospholipid Hydroperoxide Glutathione Peroxidase

Autor:innen und Institutionen

  • Departamento de Inmunología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
  • Departamento de Hemodinámica, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
  • Programa de Maestría en Ciencias Médicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Unidad de Cuidados Coronarios, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
  • Laboratorio de Medicina Traslacional, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.

ORCID-Profile: Brandon Fisher-Bautista, Rashidi Springall, Pedro Ruiz-Garcia, Betsabé Jaramillo-Antonio, Gabriela Fonseca-Camarillo

Förderung

  • Instituto Nacional de Cardiología
  • Instituto Nacional de Cardiología Ignacio Chávez

Zitieren

APA

Priego-Ranero, Á., Fisher-Bautista, B., Springall, R., Amezcua-Guerra, L. M., González-Pacheco, H., Ruiz-Garcia, P., Jaramillo-Antonio, B., Brianza-Padilla, M., & Fonseca-Camarillo, G. (2026). Circulating 4-Hydroxynonenal Is Associated with Clinical Severity in ST-Segment Elevation Myocardial Infarction. International Journal of Molecular Sciences, 27(21), 9694. https://doi.org/10.3390/ijms27219694

Vancouver

Priego-Ranero Á, Fisher-Bautista B, Springall R, Amezcua-Guerra LM, González-Pacheco H, Ruiz-Garcia P, et al. Circulating 4-Hydroxynonenal Is Associated with Clinical Severity in ST-Segment Elevation Myocardial Infarction. International Journal of Molecular Sciences. 2026;27(21):9694. doi:10.3390/ijms27219694

BibTeX
@article{PriegoRanero2026,
  author = {Priego-Ranero, Ángel and Fisher-Bautista, Brandon and Springall, Rashidi and Amezcua-Guerra, Luis M and González-Pacheco, Héctor and Ruiz-Garcia, Pedro and Jaramillo-Antonio, Betsabé and Brianza-Padilla, Malinalli and Fonseca-Camarillo, Gabriela},
  title = {Circulating 4-Hydroxynonenal Is Associated with Clinical Severity in ST-Segment Elevation Myocardial Infarction},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9694},
  doi = {10.3390/ijms27219694}
}
Kostenlos starten →